Clinical Trials in Chicago

Showing 9901-9920 of 15,574 trials

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

NCT02043860

In this phase I trial, patients with multiple myeloma will receive standard high dose melphalan with autologous stem cell rescue. In addition the pre-transplant conditioning will include targeted total marrow irradiation (TMI). This conventional 3+3 phase I trial will increase the dose of TMI until the maximum tolerated dose (MTD) is reached. Initial patients enrolled will receive the lowest possible dose of 3Gy. Maximum dose will be 12Gy.

Multiple Myeloma

University of Illinois at Chicago3 participantsStarted Jan 2014

Chicago, Illinois, United States

TERMINATEDPhase 32.2 miles

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

NCT01390220

The purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.

Epilepsy

UCB Biopharma S.P.R.L.292 participantsStarted Jun 2011

Phoenix, Arizona, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +87 more locations

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Find Trials by Condition in Chicago

Trial of IMO-8400 in Adult Patients With Dermatomyositis

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers

e-NOBORI Observational Registry of Nobori DES